Joseph Burnett, CEO and President at ClearPoint Neuro, Inc. (CLPT), sold 52,626 shares at $26.51 ($1.4M) on 2025-10-10, disclosed to the SEC on 2025-10-14.
Scheduled sale ($1.4M) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.51 | 17,583 | $466K | 32.8% |
| 2 | $26.51 | 17,583 | $466K | 32.8% |
| 3 | $27.64 | 6,599 | $182K | 12.9% |
| 4 | $27.64 | 6,599 | $182K | 12.9% |
| 5 | $28.64 | 1,981 | $57K | 4.0% |
| 6 | $28.64 | 1,981 |
| $57K |
| 4.0% |
| 7 | $29.21 | 300 | $9K | 0.6% |
| Total | $26.97 avg | 52,626 | $1.4M | 100% |
| Filing → |
| CLPT | SELL | 2026-02-26 | $303K | — | Filing → |
| CLPT | SELL | 2026-01-27 | $46K | — | Filing → |
| CLPT | SELL | 2026-01-13 | $322K | — | Filing → |